Biostime Surges to Record on Purchase of Health-Supplement Maker

Updated on
  • Chinese baby formula maker buys Australia's Swisse Wellness
  • Biostime arranges $450 million in bridge financing for deal

Biostime International Holdings Ltd., the Chinese infant formula producer, surged to a record in Hong Kong trading after agreeing to take control of Australian health-supplement maker Swisse Wellness Group Pty for A$1.3 billion ($934 million).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.